Pub Date : 2025-12-10DOI: 10.1038/d41573-025-00204-w
Andrew Shui-Jezierski
{"title":"Upcoming FDA approval decisions in Q1 2026","authors":"Andrew Shui-Jezierski","doi":"10.1038/d41573-025-00204-w","DOIUrl":"10.1038/d41573-025-00204-w","url":null,"abstract":"","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 1","pages":"11-11"},"PeriodicalIF":101.8,"publicationDate":"2025-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/d41573-025-00204-w.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145724837","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-05DOI: 10.1038/d41573-025-00202-y
Asher Mullard
{"title":"First-in-class APRIL inhibitor secures approval for rare kidney disease","authors":"Asher Mullard","doi":"10.1038/d41573-025-00202-y","DOIUrl":"10.1038/d41573-025-00202-y","url":null,"abstract":"","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 1","pages":"9-9"},"PeriodicalIF":101.8,"publicationDate":"2025-12-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145680547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03DOI: 10.1038/d41573-025-00198-5
Christelle Bouygues, Anna Tavridou, Ralf Herold, Yoana Nuevo-Ordoñez
{"title":"Stimulating medicines repurposing in the EU: a pilot project","authors":"Christelle Bouygues, \u0000 Anna Tavridou, \u0000 Ralf Herold, \u0000 Yoana Nuevo-Ordoñez","doi":"10.1038/d41573-025-00198-5","DOIUrl":"10.1038/d41573-025-00198-5","url":null,"abstract":"","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 1","pages":"12-13"},"PeriodicalIF":101.8,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.comhttps://www.nature.com/articles/d41573-025-00198-5.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145664130","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-02DOI: 10.1038/d41573-025-00200-0
Alex Eccleston
{"title":"Omics with active learning optimizes phenotypic screens","authors":"Alex Eccleston","doi":"10.1038/d41573-025-00200-0","DOIUrl":"10.1038/d41573-025-00200-0","url":null,"abstract":"","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"25 1","pages":"19-19"},"PeriodicalIF":101.8,"publicationDate":"2025-12-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145657020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
扫码关注我们
求助内容：
应助结果提醒方式：